nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Hyoscyamine—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Hyoscyamine—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Hyoscyamine—Abdominal distension—Prednisone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Hyoscyamine—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Hyoscyamine—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Hyoscyamine—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Hyoscyamine—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Hyoscyamine—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Hyoscyamine—Lethargy—Methotrexate—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Hyoscyamine—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Hyoscyamine—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Hyoscyamine—Erythema—Prednisolone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Hyoscyamine—Bradycardia—Betamethasone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Hyoscyamine—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Hyoscyamine—Irritability—Methotrexate—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Hyoscyamine—Hallucination—Dexamethasone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Hyoscyamine—Hallucination—Betamethasone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Hyoscyamine—Ataxia—Methotrexate—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Hyoscyamine—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Hyoscyamine—Vision blurred—Prednisolone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Hyoscyamine—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Hyoscyamine—Depression—Prednisone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Hyoscyamine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Hyoscyamine—Erythema—Triamcinolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Hyoscyamine—Erythema—Methylprednisolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Hyoscyamine—Angioedema—Prednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Hyoscyamine—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Hyoscyamine—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Hyoscyamine—Vertigo—Prednisolone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Hyoscyamine—Syncope—Prednisolone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Hyoscyamine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Hyoscyamine—Convulsion—Prednisolone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Hyoscyamine—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Hyoscyamine—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Hyoscyamine—Bradycardia—Prednisone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Hyoscyamine—Angioedema—Triamcinolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Hyoscyamine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Hyoscyamine—Erythema—Betamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Hyoscyamine—Erythema—Dexamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Hyoscyamine—Hallucination—Prednisone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Hyoscyamine—Vertigo—Triamcinolone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Hyoscyamine—Syncope—Triamcinolone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Hyoscyamine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Hyoscyamine—Syncope—Methylprednisolone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Hyoscyamine—Oedema—Prednisolone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Hyoscyamine—Dysuria—Methotrexate—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Hyoscyamine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Hyoscyamine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Hyoscyamine—Shock—Prednisolone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Hyoscyamine—Convulsion—Triamcinolone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Hyoscyamine—Tachycardia—Prednisolone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Hyoscyamine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Hyoscyamine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Hyoscyamine—Drowsiness—Methotrexate—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Hyoscyamine—Depression—Methotrexate—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Hyoscyamine—Flushing—Prednisone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Hyoscyamine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Hyoscyamine—Angioedema—Dexamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Hyoscyamine—Angioedema—Betamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Hyoscyamine—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Hyoscyamine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Hyoscyamine—Oedema—Triamcinolone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Hyoscyamine—Vertigo—Dexamethasone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Hyoscyamine—Vertigo—Betamethasone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Hyoscyamine—Syncope—Dexamethasone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Hyoscyamine—Syncope—Betamethasone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Hyoscyamine—Arrhythmia—Prednisone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Hyoscyamine—Sweating—Methotrexate—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Hyoscyamine—Shock—Triamcinolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Hyoscyamine—Insomnia—Prednisolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Hyoscyamine—Shock—Methylprednisolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Hyoscyamine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Hyoscyamine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Hyoscyamine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Hyoscyamine—Mental disorder—Prednisone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Hyoscyamine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Hyoscyamine—Erythema—Prednisone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Hyoscyamine—Convulsion—Dexamethasone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Hyoscyamine—Convulsion—Betamethasone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Hyoscyamine—Anxiety—Betamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Hyoscyamine—Anxiety—Dexamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Hyoscyamine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Hyoscyamine—Pain—Prednisolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Hyoscyamine—Vision blurred—Prednisone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Hyoscyamine—Oedema—Dexamethasone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Hyoscyamine—Oedema—Betamethasone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Hyoscyamine—Insomnia—Triamcinolone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Hyoscyamine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Hyoscyamine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Hyoscyamine—Shock—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Hyoscyamine—Shock—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Hyoscyamine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Hyoscyamine—Agitation—Prednisone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Hyoscyamine—Tachycardia—Betamethasone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Hyoscyamine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Hyoscyamine—Angioedema—Prednisone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Hyoscyamine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Hyoscyamine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Hyoscyamine—Vertigo—Prednisone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Hyoscyamine—Syncope—Prednisone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Hyoscyamine—Urticaria—Prednisolone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Hyoscyamine—Fatigue—Triamcinolone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Hyoscyamine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Hyoscyamine—Pain—Triamcinolone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Hyoscyamine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Hyoscyamine—Hypotension—Dexamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Hyoscyamine—Hypotension—Betamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Hyoscyamine—Convulsion—Prednisone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Hyoscyamine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Hyoscyamine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Hyoscyamine—Anxiety—Prednisone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Hyoscyamine—Insomnia—Dexamethasone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Hyoscyamine—Insomnia—Betamethasone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Hyoscyamine—Mental disorder—Methotrexate—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Hyoscyamine—Erythema—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Hyoscyamine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Hyoscyamine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Hyoscyamine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Hyoscyamine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Hyoscyamine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Hyoscyamine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Hyoscyamine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Hyoscyamine—Oedema—Prednisone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Hyoscyamine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Hyoscyamine—Fatigue—Dexamethasone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Hyoscyamine—Fatigue—Betamethasone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Hyoscyamine—Shock—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Hyoscyamine—Pain—Dexamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Hyoscyamine—Pain—Betamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Hyoscyamine—Tachycardia—Prednisone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Hyoscyamine—Vision blurred—Methotrexate—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Hyoscyamine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Hyoscyamine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Hyoscyamine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Hyoscyamine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Hyoscyamine—Vertigo—Methotrexate—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Hyoscyamine—Urticaria—Betamethasone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Hyoscyamine—Urticaria—Dexamethasone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Hyoscyamine—Dizziness—Prednisolone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Hyoscyamine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Hyoscyamine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Hyoscyamine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Hyoscyamine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Hyoscyamine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Hyoscyamine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Hyoscyamine—Insomnia—Prednisone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Hyoscyamine—Pruritus—Triamcinolone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Hyoscyamine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Hyoscyamine—Convulsion—Methotrexate—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Hyoscyamine—Dyspepsia—Prednisone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Hyoscyamine—Chest pain—Methotrexate—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Hyoscyamine—Rash—Prednisolone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Hyoscyamine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Hyoscyamine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Hyoscyamine—Fatigue—Prednisone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Hyoscyamine—Headache—Prednisolone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Hyoscyamine—Constipation—Prednisone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Hyoscyamine—Confusional state—Methotrexate—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Hyoscyamine—Dizziness—Triamcinolone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Hyoscyamine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Hyoscyamine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Hyoscyamine—Asthenia—Dexamethasone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Hyoscyamine—Asthenia—Betamethasone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Hyoscyamine—Nausea—Prednisolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Hyoscyamine—Pruritus—Betamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Hyoscyamine—Pruritus—Dexamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Hyoscyamine—Vomiting—Triamcinolone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Hyoscyamine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Hyoscyamine—Rash—Triamcinolone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Hyoscyamine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Hyoscyamine—Rash—Methylprednisolone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Hyoscyamine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Hyoscyamine—Urticaria—Prednisone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Hyoscyamine—Headache—Triamcinolone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Hyoscyamine—Headache—Methylprednisolone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Hyoscyamine—Body temperature increased—Prednisone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Hyoscyamine—Abdominal pain—Prednisone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Hyoscyamine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Hyoscyamine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Hyoscyamine—Hypotension—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Hyoscyamine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Hyoscyamine—Dizziness—Betamethasone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Hyoscyamine—Insomnia—Methotrexate—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Hyoscyamine—Nausea—Triamcinolone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Hyoscyamine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Hyoscyamine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Hyoscyamine—Somnolence—Methotrexate—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Hyoscyamine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Hyoscyamine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Hyoscyamine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Hyoscyamine—Vomiting—Betamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Hyoscyamine—Rash—Dexamethasone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Hyoscyamine—Rash—Betamethasone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Hyoscyamine—Dermatitis—Betamethasone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Hyoscyamine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Hyoscyamine—Fatigue—Methotrexate—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Hyoscyamine—Headache—Betamethasone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Hyoscyamine—Headache—Dexamethasone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Hyoscyamine—Asthenia—Prednisone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Hyoscyamine—Pain—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Hyoscyamine—Pruritus—Prednisone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Hyoscyamine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000992	0.000992	CcSEcCtD
Hyoscyamine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000985	0.000985	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000984	0.000984	CcSEcCtD
Hyoscyamine—Nausea—Betamethasone—ankylosing spondylitis	0.000982	0.000982	CcSEcCtD
Hyoscyamine—Nausea—Dexamethasone—ankylosing spondylitis	0.000982	0.000982	CcSEcCtD
Hyoscyamine—Urticaria—Methotrexate—ankylosing spondylitis	0.000956	0.000956	CcSEcCtD
Hyoscyamine—Dizziness—Prednisone—ankylosing spondylitis	0.000952	0.000952	CcSEcCtD
Hyoscyamine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000951	0.000951	CcSEcCtD
Hyoscyamine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000951	0.000951	CcSEcCtD
Hyoscyamine—Vomiting—Prednisone—ankylosing spondylitis	0.000916	0.000916	CcSEcCtD
Hyoscyamine—Rash—Prednisone—ankylosing spondylitis	0.000908	0.000908	CcSEcCtD
Hyoscyamine—Dermatitis—Prednisone—ankylosing spondylitis	0.000907	0.000907	CcSEcCtD
Hyoscyamine—Headache—Prednisone—ankylosing spondylitis	0.000902	0.000902	CcSEcCtD
Hyoscyamine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000887	0.000887	CcSEcCtD
Hyoscyamine—Asthenia—Methotrexate—ankylosing spondylitis	0.000863	0.000863	CcSEcCtD
Hyoscyamine—Nausea—Prednisone—ankylosing spondylitis	0.000855	0.000855	CcSEcCtD
Hyoscyamine—Pruritus—Methotrexate—ankylosing spondylitis	0.000851	0.000851	CcSEcCtD
Hyoscyamine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000823	0.000823	CcSEcCtD
Hyoscyamine—Dizziness—Methotrexate—ankylosing spondylitis	0.000796	0.000796	CcSEcCtD
Hyoscyamine—Vomiting—Methotrexate—ankylosing spondylitis	0.000765	0.000765	CcSEcCtD
Hyoscyamine—Rash—Methotrexate—ankylosing spondylitis	0.000759	0.000759	CcSEcCtD
Hyoscyamine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000758	0.000758	CcSEcCtD
Hyoscyamine—Headache—Methotrexate—ankylosing spondylitis	0.000754	0.000754	CcSEcCtD
Hyoscyamine—Nausea—Methotrexate—ankylosing spondylitis	0.000715	0.000715	CcSEcCtD
